Even if we assume that the identified p.[Asp118Asn];[Trp422Arg] variants represent a clinically relevant TSHR genotype, these defects seem to be a very uncommon genetic etiological factor for CH-TD in our population (<1%, N = 1/128). Here, TSHR is linked to cyclic hematopoiesis.